JOIN DSMIG TODAY

A Randomized, Double-Blind, Placebo-Controlled, Phase II Study of Oral ELND005 (scyllo-Inositol) in Young Adults with Down Syndrome without Dementia.

18 May 2017 3:34 PM | Anonymous member (Administrator)

Recently published in JAD, https://www.ncbi.nlm.nih.gov/pubmed/28453471



Down Syndrome Medical Interest Group-USA

DSMIG-USA is a 501(3)(c) Organization

Contact Us

Site Design by:  Site to be Seen


Powered by Wild Apricot Membership Software